255 related articles for article (PubMed ID: 27689335)
21. Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: induction of argininosuccinate synthetase by cytokines.
Flodström M; Niemann A; Bedoya FJ; Morris SM; Eizirik DL
Endocrinology; 1995 Aug; 136(8):3200-6. PubMed ID: 7628352
[TBL] [Abstract][Full Text] [Related]
22. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.
Long Y; Tsai WB; Wang D; Hawke DH; Savaraj N; Feun LG; Hung MC; Chen HH; Kuo MT
Cancer Lett; 2017 Mar; 388():54-63. PubMed ID: 27913198
[TBL] [Abstract][Full Text] [Related]
23. Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53.
Miyamoto T; Lo PHY; Saichi N; Ueda K; Hirata M; Tanikawa C; Matsuda K
Sci Adv; 2017 May; 3(5):e1603204. PubMed ID: 28560349
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
Syed N; Langer J; Janczar K; Singh P; Lo Nigro C; Lattanzio L; Coley HM; Hatzimichael E; Bomalaski J; Szlosarek P; Awad M; O'Neil K; Roncaroli F; Crook T
Cell Death Dis; 2013 Jan; 4(1):e458. PubMed ID: 23328665
[TBL] [Abstract][Full Text] [Related]
25. Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.
Zou Z; Hu X; Luo T; Ming Z; Chen X; Xia L; Luo W; Li J; Xu N; Chen L; Cao D; Wen M; Kong F; Peng K; Xie Y; Li X; Ma D; Yang C; Chen C; Yi W; Liu O; Liu S; Luo J; Luo Z
Nat Commun; 2021 Apr; 12(1):2263. PubMed ID: 33859183
[TBL] [Abstract][Full Text] [Related]
26. PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction.
Verma M; Charles RCM; Chakrapani B; Coumar MS; Govindaraju G; Rajavelu A; Chavali S; Dhayalan A
J Mol Biol; 2017 Jul; 429(15):2278-2289. PubMed ID: 28587924
[TBL] [Abstract][Full Text] [Related]
27. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance.
Huang HY; Wu WR; Wang YH; Wang JW; Fang FM; Tsai JW; Li SH; Hung HC; Yu SC; Lan J; Shiue YL; Hsing CH; Chen LT; Li CF
Clin Cancer Res; 2013 Jun; 19(11):2861-72. PubMed ID: 23549872
[TBL] [Abstract][Full Text] [Related]
28. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
[TBL] [Abstract][Full Text] [Related]
29. Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses.
Mao Y; Shi D; Li G; Jiang P
Mol Cell; 2022 Feb; 82(3):527-541.e7. PubMed ID: 35016033
[TBL] [Abstract][Full Text] [Related]
30. Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.
Mörén L; Perryman R; Crook T; Langer JK; Oneill K; Syed N; Antti H
BMC Cancer; 2018 Feb; 18(1):167. PubMed ID: 29422017
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.
Chu CY; Lee YC; Hsieh CH; Yeh CT; Chao TY; Chen PH; Lin IH; Hsieh TH; Shih JW; Cheng CH; Chang CC; Lin PS; Huang YL; Chen TM; Yen Y; Ann DK; Kung HJ
Theranostics; 2021; 11(8):3624-3641. PubMed ID: 33664852
[TBL] [Abstract][Full Text] [Related]
32. Relative argininosuccinate synthetase mRNA levels and gene copy number in canavanine-resistant lymphoblasts.
Amos JA; Fleming BC; Gusella JF; Jacoby LB
Biochim Biophys Acta; 1984 Jul; 782(3):247-53. PubMed ID: 6733108
[TBL] [Abstract][Full Text] [Related]
33. Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers.
Kremer JC; Prudner BC; Lange SES; Bean GR; Schultze MB; Brashears CB; Radyk MD; Redlich N; Tzeng SC; Kami K; Shelton L; Li A; Morgan Z; Bomalaski JS; Tsukamoto T; McConathy J; Michel LS; Held JM; Van Tine BA
Cell Rep; 2017 Jan; 18(4):991-1004. PubMed ID: 28122247
[TBL] [Abstract][Full Text] [Related]
34. Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells.
Vynnytska BO; Mayevska OM; Kurlishchuk YV; Bobak YP; Stasyk OV
Anticancer Drugs; 2011 Feb; 22(2):148-57. PubMed ID: 20717004
[TBL] [Abstract][Full Text] [Related]
35. Arginine-mediated regulation of an argininosuccinate synthetase minigene in normal and canavanine-resistant human cells.
Jackson MJ; O'Brien WE; Beaudet AL
Mol Cell Biol; 1986 Jun; 6(6):2257-61. PubMed ID: 3785195
[TBL] [Abstract][Full Text] [Related]
36. Improved standards for prenatal diagnosis of citrullinemia.
Miller MJ; Soler-Alfonso CR; Grund JE; Fang P; Sun Q; Elsea SH; Sutton VR
Mol Genet Metab; 2014 Jul; 112(3):205-9. PubMed ID: 24889030
[TBL] [Abstract][Full Text] [Related]
37. Bench-to-Bedside Studies of Arginine Deprivation in Cancer.
Field GC; Pavlyk I; Szlosarek PW
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903394
[TBL] [Abstract][Full Text] [Related]
38. Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment.
Rogers LC; Kremer JC; Brashears CB; Lin Z; Hu Z; Bastos ACS; Baker A; Fettig N; Zhou D; Shoghi KI; Dehner CA; Chrisinger JSA; Bomalaski JS; Garcia BA; Oyama T; White EP; Van Tine BA
Clin Cancer Res; 2023 Aug; 29(16):3189-3202. PubMed ID: 37339179
[TBL] [Abstract][Full Text] [Related]
39. Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review.
Lin Y; Gao H; Lu B; Zhou S; Zheng T; Lin W; Zhu L; Jiang M; Fu Q
BMC Med Genet; 2019 Jun; 20(1):110. PubMed ID: 31208364
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
